Back

Empagliflozin improves prognosis and energetic properties through modulating mitochondrial function in failing murine hearts

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Novel therapies for heart failure in the early pipeline Experimental Heart Failure ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Aya Shiraki

Saga University, Saga (Japan)

2 More presentations in this session

Presentation thumbnail
Low level transcutaneous vagus nerve stimulation reverses cardiac dysfunction and changes left ventricular gene expression in a rat model of heart failure with preserved ejection fraction
Doctor M. Niewiadomska (Oklahoma City, US)
Abstract Slides Video
Presentation thumbnail
Therapeutic role of Prostaglandin E2 receptor 4 stimulation in inflammatory cardiomyopathy
Doctor T. Akira (Yokohama, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Novel therapies for heart failure in the early pipeline

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Coronary microvascular dysfunction in heart failure: observations from the MICRO registry
thumbnail
Congress Session
Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources